Page last updated: 2024-08-26

diprotin a and Myocardial Infarction

diprotin a has been researched along with Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashraf, A; Ashraf, M; Dai, B; Huang, W; Millard, RW; Wang, Y; Zhang, D; Zhao, T1
Assmann, G; Brunner, S; Fischer, R; Franz, WM; Gröbner, M; Hacker, M; Huber, B; Krieg, L; Mueller-Hoecker, J; Rischpler, C; Theiss, HD; Vallaster, M; Vanchev, Y; Wollenweber, T; Zaruba, MM1

Other Studies

2 other study(ies) available for diprotin a and Myocardial Infarction

ArticleYear
Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:5

    Topics: Adenoviridae; Animals; Chemokine CXCL12; Combined Modality Therapy; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Heart; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Models, Animal; Myocardial Infarction; Neovascularization, Physiologic; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Ventricular Function, Left

2010
Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
    Stem cell research, 2011, Volume: 7, Issue:3

    Topics: Animals; Antigens, CD34; Benzylamines; Chemokine CXCL12; Cyclams; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Granulocyte Colony-Stimulating Factor; Heart Function Tests; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Leukocyte Common Antigens; Mice; Models, Biological; Myocardial Infarction; Neovascularization, Physiologic; Oligopeptides; Perfusion; Proto-Oncogene Proteins c-kit; Receptors, CXCR4; Stem Cell Transplantation; Survival Analysis

2011